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Abstract
Parkinson's disease (PD) is the second most common form of human degenerative disorder.
Mutation of parkin is one of the most prevalent causes of autosomal recessive PD. Parkin is an E3
ubiquitin ligase that acts on a variety of substrates, resulting in polyubiquitination and degradation
by the proteasome or monoubiquitination and regulation of biological activity. However, the
cellular functions of parkin that relate to its pathological involvement in PD are not well
understood. Here I show that parkin translocates into nucleus upon DNA damage. Nuclear
translocation of parkin appears to be required to promote DNA repair. These findings suggest that
DNA damage induces nuclear translocation of parkin leading to the PCNA interaction and possibly
other nuclear proteins involved in DNA repair. These results suggest that parkin promotes DNA
repair and protects against genotoxicity, and implicate DNA damage as a potential pathogenic
mechanism in parkinsonism.
Introduction
Parkin was first isolated as the candidate gene of auto-
somal recessive juvenile Parkinsonism (AR-JP) [1].
Although many types of mutations, such as point muta-
tions, truncations and/or splicing variants of parkin, are
found in Parkinson's disease (PD) patients [2], the mech-
anism of how parkin is involved in PD remains elusive. In
addition to its association with PD, parkin might be asso-
ciated with carcinogenesis and may be a tumor suppressor
[3]. Abnormal parkin transcripts have been detected in a
number of different tumor cell types, including lung, cer-
vical, pancreatic, and kidney tumors [3].
Parkin functions as an E3 ubiquitin protein ligase [1].
Based on its structure, parkin may act as a docking station
bringing substrate proteins to an E2 ubiquitin conjugating
enzyme for ubiquitination, thus leading to their degrada-
tion [4]. Several parkin interacting proteins have been
identified, including CDCrel-1 [5], glycosylated α-synu-
clein [6], synphilin-1 [7], PAEL-R [8], cyclin E [9], ami-
noacyl-tRNA synthetase cofactor p38 [10], and a PDZ
containing protein CASK/Lin2 [11]. However, the mecha-
nism by which parkin mutations cause PD remains to be
determined.
Accelerated DNA damage occurs during the aging of the
human brain [12]. Furthermore, several studies suggest
that DNA damage is involved in neurodegenerative proc-
esses [13,14]. For example, the level of the DNA damage
marker, 8-hydroxyguanine is increased in genomic DNA
in PD substantia nigra compared to non-PD controls [15].
In addition, somatic mitochondrial DNA mutations in
cortex and substantia nigra are increased in PD [16]. Fur-
thermore, it has been proposed that oxidative stress
induced DNA damage could be an important risk factor
for PD [17,18].
These observations prompted us to examine genes associ-
ated with PD for a role in DNA damage response. The cur-
rent studies provide evidence that DNA damage promotes
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nuclear translocation of parkin. These findings provide a
potential interface between normal aging associated DNA
damage and pathologic associated with neurodegenera-
tive disease, and is consistent with the very early onset of
PD associated with parkin mutations.
Materials and methods
Antibodies
Rabbit anti-Parkin antibodies and rabbit anti-β-actin anti-
bodies were purchased from Cell Signaling. Mouse anti-
PCNA antibodies were from Santa Cruz Biotechnology.
Goat anti-8-OHdG antibodies and mouse anti-lamin B
antibodies were obtained from Chemicon, and mouse
anti-CPD was from MBL.
Cells and tissues
SH-SY5Y human neuroblastoma cells and HeLa cells were
grown in DMEM supplemented with 10% fetal bovine
serum. Parkin and parkin mutant (Del 3–4) stable cells
were established by transfecting pcDNA3.1(-)-Parkin or
pcDNA3.1(-)-Parkin-Del 3–4 into SY5Y cells, and selected
by geneticin. Post-mortem human cortical samples were
described previously [12].
Chromatin immunoprecipitation
The association of parkin with calmodulin 1 promoter
was assayed by chromatin immunoprecipitation (ChIP)
using the ChIP assay protocol (Upstate) with some modi-
fications. Brain tissue samples were prepared as described
before [12]. HeLa cells transfected with parkin and UV
damaged or undamaged calmodulin promoter constructs
was harvested according to ChIP assay protocol. The
amount of DNA in the resulting cell lysates was quantified
by measuring absorption at 260 nm, and then adjusted to
100 μg/μl. 200 μg supernatant was diluted 10-fold in 2 ml
ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2
mM EDTA, 16.7 mM Tris-HCl, pH 8.1, 167 mM NaCl, and
protease inhibitors), and precleared twice with BSA-
blocked Protein L Agarose (Pierce) (2 × 100 μg, 2 × 30 min
at 4°C). The beads were centrifuged and the supernatant
was divided into 4 × 500 μl aliquots for immunoprecipi-
tation, input DNA, and the IgG control. Primary antibody
was added and incubated at 4°C overnight. A rabbit anti-
parkin polyclonal antibody (Cell signaling) was used for
immunoprecipitation of Parkin, and ChromPure rabbit
IgG (Jackson ImmunoResaerch) was used for the IgG con-
trol. 30/μl of BSA-blocked Protein L Agarose was then
added and incubated at 4°C with rotation. The beads were
then centrifuged and washed once with a low salt immune
complex buffer (Upstate), twice with a high salt wash
buffer, once with a LiCl wash buffer (Upstate), and twice
in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). The
washed agarose beads were eluted with 2 × 250 μl freshly
prepared elution buffer (1% SDS, 0.1 mM NaHCO3).
DNA crosslinking was reversed by adding 5 M NaCl and
heating at 65°C for 4 hrs. Protein was removed by incuba-
tion with 20 mg/ml proteinase K in 10 μg EDTA/40 mM
Tris-HCl, pH 6.5 for 1 hr at 45°C. De-crosslinked DNA
was then isolated by phenol/chloroform extraction and
ethanol precipitation. The precipitated DNA was washed
with 70% ethanol, air dried and dissolved in ddH2O for
PCR.
Induction of DNA damage
UV-irradiation was performed by irradiating SH-SY5Y
cells with UV-C light (254 nm, 60 J/m2) using a Strata-
linker (Stratagene). Oxidative DNA damage was per-
formed on SH-SY5Y cells treated with H2O2 (300 μM) for
overnight. Double strand break DNA damage was
induced by treatment with 50 μM etoposide (Calbio-
chem) for overnight.
Immunohistochemical staining of DNA cyclopyrimidine 
dimers (CPD)
Immunohistochemical staining of CPD was performed
after irradiating SH-SY5Y cells with 100 J/M2 of 254 nm
UV light using a microfliter (Millipore). Cells were then
fixed 1 hr or 12 hr later with 4% paraformaldehyde, per-
meabilized for 15 min in 0.4% Triton X-100 (Sigma) in
PBS, and the DNA was denatured in 2 M HCl for 30 min
at room temperature. After blocking with FBS, cells were
incubated with anti-CPD antibody (1:3000) for 30 min.
The sections were then incubated with Cy3-conjugated
anti-goat IgG (Jackson ImmunoResearch) at room tem-
perature for 30 min and then with Hoechst dye for 5 min.
The sections were analyzed by fluorescence transmission
or confocal microscopy.
Host cell reactivation assays
The host cell reactivation assay (HCR) was performed as
described previously [19,20]. A pTK-Renilla reporter plas-
mid was damaged by exposure to UV-C light (254 nm) at
250 J/m2 in vitro, which markedly reduces its expression.
SH-SY5Y cells were then transfected with UV-irradiated or
control non-irradiated pTK-Renilla expression vectors.
Each plate was co-transfected with a control firefly luci-
ferase vector (pGL3-basic) to control for transfection effi-
ciency. Cells lysis was performed 24 hours after
transfection, renilla and firefly luciferase activities were
measured, and renilla luciferase activity was normalized
to the firefly luciferase activity in the same plate. Renilla
luciferase activity of the control undamaged plasmid was
normalized to 100%, and compared with the expression
of the UV-irradiated reporter plasmid in the same cell
type.
Results
DNA damage and nuclear translocation of parkin
I first asked if parkin is translocated to the nucleus upon
DNA damage. To assess nuclear translocation, SH-SY5YJournal of Biomedical Science 2009, 16:67 http://www.jbiomedsci.com/content/16/1/67
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cells stably over-expressing parkin were analyzed by sub-
cellular fractionation after exposure to agents that induce
DNA damage. Cell lysates were separated into nuclear and
cytoplasmic fractions, and parkin was resolved by immu-
noblotting (Fig 1, top). The ratio of nuclear to cytoplasmic
parkin was significantly increased after UV irradiation,
treatment with H2O2, and treatment with etoposide,
which selectively induces DNA double strand breaks (Fig
1A, bottom). Absence of cross-contamination of the frac-
tions was confirmed by immunoblotting for lamin B, a
nuclear marker, and β-actin, a cytoplasmic marker. Thus,
a variety of different DNA damaging insults can induce
the nuclear translocation of parkin.
The nuclear translocation of parkin was confirmed by
immunofluorescence assays. SH-SY5Y cells stably over-
expressing parkin were irradiated by UV-C light (60 J/M2).
The nuclear translocation of parkin was assayed 2 hr after
treatment. Parkin expression was mainly cytoplasmic
without UV irradiation (Fig 1B, top), while the expression
of parkin in the nucleus was greatly increased after UV
irradiation (Fig 1B, bottom). These results confirmed the
nuclear translocation of parkin after DNA damage.
Parkin associates with damaged DNA
To further explore whether parkin is involved in DNA
damage repair, I examined whether parkin associated with
damaged DNA. A human calmodulin 1 promoter con-
struct was either UV irradiated in vitro or untreated, and
then was co-transfected with a parkin construct into HeLa
cells. The human calmodulin 1 promoter was chosen
because it was preferentially damaged in human ageing
brain [12], and the HeLa cell line was used because HeLa
cells contain a parkin  gene deletion [21] and may not
express functional parkin protein [22,23]. ChIP assays
were performed to determine the association between
parkin and DNA. There was a weak interaction between
parkin and untreated calmodulin 1 promoter (Fig. 2A),
however such interaction was significantly increased
when DNA was damaged by UV irradiation (Fig. 2A).
To demonstrate that parkin associated with damage DNA
also occurred in human brain tissues with endogenous
damaged DNA, I next investigated the association
between parkin and the endogenous calmodulin 1 pro-
moter in normal human brain tissues. After analyzing tis-
sue samples from 4 young brains (<40-year-old) and 4 old
brains (>70-year-old), ChIP assays showed a much
stronger association between parkin and calmodulin 1
promoter in the aged brain tissues than that in young
brain tissues (Fig. 2B). Since there were higher levels of
DNA damage in aged human brains as shown by the pres-
ence of high level of 8-OHdG in calmodulin 1 promoter
(Fig. 2B, bottom), these results suggest that parkin is asso-
ciated with damaged DNA in vivo.
Parkin reduces DNA damage induced by UV irradiation
Since parkin associates with damaged DNA complex, this
observation prompted me to ask whether parkin is
involved in the process of DNA repair. To address this
question, DNA damage was induced by UV irradiation of
SH-SY5Y cells that stably over-express wild-type parkin or
control expression plasmids. DNA damage was examined
by immunofuorescence microscopy with an antibody to
cyclobutane pyrimidine dimers (CPD), a major DNA
adduct induced by UV irradiation. UV irradiation induced
substantial DNA damage in all three cell lines as indicated
by robust nuclear immunoreactivity for CPD (Fig. 3, top,
1 hr post-treatment). This damage was markedly reduced
by over-expression of wild-type parkin after 12 hr (Fig. 3,
top, 12 hr post-treatment). In contrast, over-expression of
a parkin exon 3–4 deletion construct, which is associated
with autosomal recessive PD, did not appear to reduce
UV-induced CPD immunoreactivity (Fig 3, top, 12 hr
post-treatment, and bottom).
Nuclear localized parkin promotes DNA excision repair
In a previous study, I have shown that parkin interacts
with proliferating cell nuclear antigen (PCNA), and pro-
motes DNA excision repair [24]. I next tested whether
nuclear translocation is important for the promotion of
DNA excision repair by parkin. Host cell reaction assays
were used to determine the ability of parkin to promote
nucleotide excision repair. I found that the over-expres-
sion of parkin could facilitate DNA repair. In the HCR
assays, UV damaged or control renilla reporter constructs
were transfected into SH-SY5Y cells together with parkin
expression constructs, parkin Del 3–4, or vector backbone
pcDNA3.1. Wild type Parkin transfected cells had approx-
imate 30% higher cellular DNA repair activity than mock-
transfected cells (Fig. 4A), while the Parkin Del 3–4
mutant had little effect on DNA repair. This result indi-
cates that Parkin facilitates DNA repair induced by UV
irradiation.
Parkin is shown to be localized dominantly cytoplasm
with some fraction of parkin expressed in mitochondria
and nucleus. To further explore the importance of nuclear
translocation and regulation of DNA repair by parkin, sev-
eral parkin expressing plasmids were constructed. The
nuclear localization signal (NLS) of SV40 large T antigen
[25] and the nuclear export signal (NES) of HIV Rev [26]
were inserted upstream of parkin coding sequences
respectively so that parkin can be localized exclusively in
either cell nucleus (Parkin-NLS) or cytoplasm (Parkin-
NES) in SH-SY5Y cells. I next tested the ability of these
constructs to regulate DNA repair activity. Using HCR
assays, wild type Parkin and Parkin-NLS facilitate DNA
repair more than 30% compared to control cells (Fig. 4B),
while Parkin-NES had little effect on DNA repair, indicat-Journal of Biomedical Science 2009, 16:67 http://www.jbiomedsci.com/content/16/1/67
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Figure 1 (see legend on next page)
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DNA damage and nuclear translocation of parkin Figure 1 (see previous page)
DNA damage and nuclear translocation of parkin. (A) DNA induces nuclear translocation of parkin. SH-SY5Y cells sta-
bly transfected with parkin were UV-irradiated (60 J/m2), or treated with H2O2 (300 μM) or etoposide (50 μM) to induce DNA 
damage, followed by the isolation of nuclear and cytoplasmic fractions and resolution of parkin by immunoblotting. Note that 
each DNA damaging agent induced an increase in the absolute and relative levels of parkin in the nucleus. Absence of cross-
contamination of the fractions was confirmed by immunoblotting for lamin B, a nuclear marker, and β-actin, a cytoplasmic 
marker. Quantitation of the relative nuclear ratio of parkin is shown, and represents the mean ± S.D., n = 3. *P < 0.05 relative 
to control by ANOVA with post-hoc Student Neumann-Kiels tests. (B) Nuclear translocation of parkin in SH-SY5Y cells was 
confirmed by immunofluorescence assays. SH-SY5Y cells stably over-expressing parkin were UV-irradiated (60 J/m2) or mock-
treated. Two hours later the cellular localization of parkin was determined by immunofluorescent microscopy. Green: parkin. 
Blue: Hoechst staining of nucleus.
Parkin interacts with damaged DNA Figure 2
Parkin interacts with damaged DNA. (A) Parkin was co-transfected in HeLa cells with a calmodulin 1 promoter construct 
under control conditions (-UV) or after the calmodulin construct was damaged by UV irradiation in vitro (+UV)(100 J/M2). To 
determine whether parkin interacts with damaged DNA, parkin was immunoprecipitated followed by PCR amplification of the 
calmodulin promoter construct. Note the markedly increased co-precipitation of parkin with DNA damaged by UV irradiation. 
Input DNA, non-specific IgG controls, and parkin, β-actin immunoblots are shown. (B) Parkin binds to chromatin in the aging 
human brain. ChIP assays were performed on postmortem human cortical samples with anti-parkin or anti-8-oxoguanine fol-
lowed by PCR amplification of a calmodulin-1 promoter sequence that is damaged in human cortical samples from aged and 
young adult individuals. Note increased binding of parkin to chromatin from some aged cortical samples (≥ 73 years old) rela-
tive to young adult samples (<40 years old), which correlates with increased 8-oxoguanine content. Input and non-specific IgG 
ChIP controls are shown.
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Parkin reduces DNA damage induced by UV irradiation Figure 3
Parkin reduces DNA damage induced by UV irradiation. Stably SH-SY5Y cell lines expressing wild-type parkin, the 
Del3–4 parkin mutant, or the pcDNA control vector were UV-irradiated (100 J/M2) and then assessed for DNA damage by 
immunocytochemical staining for cyclopyrimidine dimers (CPD) (red). Nuclei were stained with Hoechst dye. All three cell 
lines show similar robust CPD staining 1 hr after UV irradiation. Decreased DNA damage in SH-SY5Y cells expressing parkin, 
but not the pcDNA control and Del3–4 parkin mutant was detected. Quantitation of CPD positive cells in three cell lines after 
UV irradiation is shown, and represents the mean ± S.D., n = 5. *P < 0.05, **P > 0.05 relative to control by ANOVA with post-
hoc Student Neumann-Kiels tests.
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ing that nuclear localized parkin is indispensable for the
regulation of DNA repair activity.
Discussion
These findings suggest that a broad range of DNA damag-
ing agents induce nuclear translocation of parkin, includ-
ing hydrogen peroxide, which induces oxidative base
damage, UV irradiation, which induces pyrimidine dimer
formation, and etoposide, which induces DNA double
strand breaks. It has been shown that parkin-deficient
mice show increased 8-oxoguanine in cerebral cortex, and
parkin promotes both base and nucleotide excision repair
in cultured cells [24]. In addition, parkin associates with
PCNA, which mediates DNA excision repair. Thus, parkin
may be involved in multiple DNA repair systems, includ-
ing base and nucleotide excision repair and double strand
break repair.
Nuclear translocation of parkin appears to be required, as
parkin fused to a nuclear export signal is unable to pro-
mote DNA repair. These findings suggest that DNA dam-
age induces nuclear translocation of parkin leading to the
Nuclear localized parkin promotes DNA excision repair Figure 4
Nuclear localized parkin promotes DNA excision repair. (A) HCR assays showed Parkin facilitates DNA repair of UV 
induced DNA lesions in SH-SY5Y cells (pTK-Renilla irradiated by UV-C at 250 J/m2). Values are expressed relative to the 
transfected undamaged reporter, and represent the mean ± s.d.; n = 3. Asterisks indicate P < 0.05 relative to control by 
ANOVA with post-hoc Student Neumann-Kiels tests. Western blot analysis showed the expression of wild type parkin and 
parkin Del3–4 mutant. (B) HCR assays showed the ability of wild type Parkin, Parkin-NLS, and Parkin-NES to regulate DNA 
repair activities. n = 3. * P < 0.05, ** P > 0.05 relative to control by ANOVA with post-hoc Student Neumann-Kiels tests. 
Western blot analysis showed the expression of wild type parkin, parkin-NLS, and parkin-NES.
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PCNA interaction and possibly other nuclear proteins
involved in DNA repair. These results also replicate the
findings of a previous report which showed that oxidative
stress can induce nuclear translocation of parkin [27]. The
mechanism of nuclear translocation remains to be deter-
mined, as parkin does not contain a canonical nuclear
localization signal. Parkin could potentially translocate in
a complex with PCNA or other DNA repair proteins trig-
gered through DNA damage-mediated signaling. In addi-
tion to PCNA, a previous report using yeast two hybrid
assays identified a parkin interaction with rad1, a compo-
nent of the rad9-hus1-rad1 protein complex involved in
DNA repair [28,29]. These results suggest that parkin pro-
motes DNA repair and protects against genotoxicity, and
implicate DNA damage as a potential pathogenic mecha-
nism in parkinsonism.
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